Worth Watching News for Traders: CytoSorbents Corporation (NASDAQ:CTSO)

On Tuesday CytoSorbents Corporation (NASDAQ:CTSO) started its trading session with the price $5.07 and closed at price of $5.07 by scoring 0.4%. Day range of the stock was $5.05 – $5.32. CTSO stock traded with total volume of 189269 shares while the average trading capacity remained 121819 shares.  Earnings per share was $-0.56. CTSO has total market capitalization of $163777330.

On Nov. 5, 2019, CytoSorbents Corporation (NASDAQ:CTSO) a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, reports financial and operational results for the quarter ending September 30, 2019.

Third Quarter 2019 Financial Results:

  • Total Q3 2019 revenues were $6.1 million, including both product sales and grant income, an increase of approximately 6%, up from $5.7 million in Q3 2018
  • Product sales for Q3 2019 were approximately $5.7 million, compared to $5.1 million for Q3 2018, an increase of approximately 12%
  • Excluding the change in the Euro to dollar exchange rate from Q3 2018 to Q3 2019, CytoSorb product sales would have been approximately $239,000 higher than actually reported, or approximately $6.0 million, an increase of 18% over Q3 2018 product sales
  • Blended product gross margins for Q3 2019 rose to 77%, compared to 72% for Q3 2018, and 76% from Q2 2019
  • Cash and cash equivalents were approximately $16 million at the end of the quarter

Leave a Reply

Your email address will not be published. Required fields are marked *